Belgium on Wednesday suspended using the J&J vaccine for individuals under age 41 after the passing of a girl who endured a clot and reduced platelets after getting the injection. The authorities said it was asked for guidance from the EU’s drug regulator, that will be reviewing the situation. No additional details were given concerning the individual beyond stating she had been below 40.